Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,432
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.5%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 201–250 of 704 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04221165	Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer	completed	Phase 2	49	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER	1	Feb 28, 2024	clinicaltrials
NCT01330446	Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer	completed	Phase 1 / Phase 2	26	M.D. Anderson Cancer CenterOTHER	1	Feb 14, 2024